FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures ...

What cannabidiol oil actually is and whether you should consider using it ...

Pharmaceutically manufactured CBD reduced patient-reported pain scores and lowered inflammatory markers in patients with ...

FibroBiologics, Inc. a annoncé la mise à disposition du troisième lot de son produit candidat CYWC628 et son expédition vers l'Australie dans le cadre de l'essai clinique de phase 1/2 en ...

(Información remitida por la empresa firmante) Madrid, 19 de agosto de 2026.- La mayor oferta disponible, el crecimiento de ...

FibroBiologics announces Australian patent accepted for cannabidiol adjuvant therapy for treatment of degenerative disc disease: Houston Friday, August 21, 2026, 16:00 Hrs [IST] F ...

Disclaimer. This content is for educational purposes only and is not a substitute for professional medical advice. If you are experiencing ongoing symptoms or concerns, consult a qualified healthcare ...

Citi Pharma Limited is seeking shareholder approval to expand its business into cannabis, industrial hemp, and medicinal ...

FibroBiologics, Inc. a annoncé l'acceptation par IP Australia de la demande de brevet australien n° 2020368344, intitulée « Cannabidiol Adjuvant Therapy for Treatment of Disc Degenerative ...

Högkostnadsskyddet för läkemedel finns till för att skydda patienter mot alltför höga kostnader för receptbelagd medicin. För läkemedel som omfattas av systemet betalar staten en allt större del av ...

La mayor oferta disponible, el crecimiento de la compra online y el acceso a más información han cambiado la forma de elegir ...